With the end of the year fast approaching, it is timely to take a step back and reflect on the challenges and achievements for 2025.
We began the year with optimism and momentum, having completed a major financing round late in 2024 (thanks to our incredible group of investors). We were preparing for filing an IND […]
Melbourne, Australia, 16 December 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead […]
The Cartherics team recently gathered at the RACV Club in Healesville for a dynamic and inspiring offsite event focused on collaboration, growth, and celebrating our shared mission.
The theme of the offsite, Stronger Together, set a positive and inclusive tone that resonated throughout the event, encouraging everyone to embrace teamwork, challenges and shared success as we […]
Melbourne, Australia, 8 December 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and […]
Melbourne, Australia, 4 December 2025 – An exciting chapter in medical innovation begins today with the official launch of Evinco Therapeutics Pty Ltd (“Evinco” or “Company”), a Melbourne-based biotechnology company developing advanced immune-based therapies for […]
Melbourne, Australia, 28 November 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian […]
Cartherics is pleased to announce that it will be presenting at the 8th Australian and New Zealand Society for Extracellular Vesicles (ANZSEV) 2025 Conference in Wellington, New Zealand. ANZSEV 2025 will showcase advances in the field across EVs and biological nanoparticles – their role in cell biology, advances in technologies for their purification and […]
Cartherics is proud to announce the successful certification of our new clean room facility, marking a significant milestone in our journey toward delivering off-the-shelf cell therapies for cancer and endometriosis.
This milestone builds on the recent unveiling of our cleanroom facility, as announced here, and reflects our continued progress in […]
Today, Cartherics proudly hosted a Frocktober Afternoon Tea in support of ovarian cancer awareness and research. Frocktober is a meaningful initiative that encourages us to go the extra style mile – turning heads, starting conversations, and raising vital funds for ovarian cancer research.
We were honoured to welcome Robin Penty, CEO of the Ovarian Cancer Research […]
Cartherics’ COO, Dr Ian Nisbet recently joined Xtalks’ Life Science Podcast to discuss Cartherics’ vision for next generation cell therapies.
He discussed how Cartherics’ platform is building an effectively unlimited supply of CAR NK cells and exploring treatments for underserved conditions like cancer and endometriosis. Dr Nisbet also reflects on his biotech leadership […]
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer, endometriosis and Alzheimer’s disease.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
